Mandaviya reviews supply and availability of Covid medicines; Buffer stock of 8 medicines created
September 01, 2021
New Delhi: Union Minister for Health and Family Welfare and Chemicals and Fertilisers, Shri Mansukh Mandaviya today reviewed the supply and availability of COVID-19 related essential medicines in the country.
During the review, it was noted that sufficient stocks of all the essential medicines are available. Raw materials for these drugs are also available in enough quantities.
The strategic buffer stock has been created for 8 drugs, all of these are available in the country. Here is the list of 8 drugs:
1. Tocilizumab
2. Methyl Predinisolone
3. Enaxopirin
4. Dexamethasone
5. Remdesivir
6. Amphotericin B Deoxycholate
7. Posaconazole
8. Intravenous Immunoglobilin (IVIG)
Senior Officials of the Ministry of Health and Family Welfare were present in the review meeting. PIB
Recent Stories
- Diwali Food Safety Drive: AMC Seals Two Units, Fines Four Outlets ₹40,000
- HDFC Bank Gets Govt Nod to Offer Deposits Under Capital Gains Accounts Scheme
- GSSSB Announces Recruitment for 1,237 Class-3 Posts; Applications Open on November 5
- AMC to Hike Parking Fees; Proposed New Rates Here
- Mumbai Mayor Ritu Tawde Meets Gujarat CM Bhupendra Patel
- Holiday Inn Resort to Come Up in Sasan Gir
